Enzychem
183490.KQEnzychem Lifesciences Corporation Price (183490.KQ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
84,929,236
(7.751)%Balance Sheet Summary
| Total Assest | |
| Total Liabilities | |
| Total Equity | |
| Total Investments | |
| Total Liabilities And Total Equ... | |
| Total debt |
Balance Sheet
Enzychem Lifesciences CorporationCurrency: KRW
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash And Cash Equivalents | 8.29B | 5.31B | 3.60B | 2.29B | 1.86B | 2.78B | 7.68B | 15.47B | |||||||||||
| Short Term Investments | 2.85B | 750.00M | 31.42B | 43.13B | 88.75B | 91.80B | 185.17B | 121.76B | |||||||||||
| Net Receivables | 0.00 | 0.00 | 0.00 | 9.53B | 4.68B | 6.11B | 10.51B | 21.36B | |||||||||||
| Inventory | 5.81B | 6.96B | 7.13B | 7.85B | 9.18B | 8.36B | 9.79B | 14.95B | |||||||||||
| Other Current Assets | 1.00B | 719.46M | 171.43M | 442.00M | 531.68M | 734.11M | 7.15B | 940.89M | |||||||||||
| Total Current Assets | 25.33B | 24.53B | 50.22B | 63.24B | 105.00B | 109.78B | 220.31B | 174.48B | |||||||||||
| Non Current Assets | |||||||||||||||||||
| Property, Plant, and Equipment, Net | 9.50B | 11.13B | 14.06B | 14.81B | 15.67B | 15.43B | 23.29B | 26.16B | |||||||||||
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.48B | |||||||||||
| Intangible Assets | 0.00 | 230.17M | 451.84M | 1.56B | 1.97B | 6.47B | 2.19B | 4.37B | |||||||||||
| Long Term Investments | 571.62M | 287.95M | 1.35B | 4.49B | 538.68M | 516.50M | 529.47M | 2.04B | |||||||||||
| Tax Assets | 0.00 | 395.27M | 62.86M | -1.00 | -1.00 | 1.00 | -1.00 | 6.00 | |||||||||||
| Other Non-Current Assets | 1.26B | 229.08M | 899.38M | 887.32M | 625.98M | 884.10M | 1.23B | 3.02B | |||||||||||
| Total Non-Current Assets | 11.34B | 12.28B | 16.82B | 21.75B | 18.80B | 23.30B | 27.24B | 37.07B | |||||||||||
| Other Assets | 1.00 | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 1.00 | 0.00 | |||||||||||
| Total Assets | 36.67B
+0% |
36.80B
+0% |
67.05B
+82% |
84.99B
+27% |
123.80B
+46% |
133.08B
+7% |
247.55B
+86% |
211.55B
-15% |
|||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Account Payables | 1.39B | 3.80B | 987.06M | 2.74B | 867.65M | 2.25B | 1.50B | 6.49B | |||||||||||
| Short Term Debt | 2.90B | 4.29B | 3.57B | 2.79B | 5.63B | 48.62B | 36.59B | 4.05B | |||||||||||
| Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 172.58M | |||||||||||
| Deferred Revenue | 0.00 | 0.00 | 26.11M | 58.14M | 127.08M | 232.68M | 130.00k | 0.00 | |||||||||||
| Other Current Liabilities | 1.74B | 1.79B | 1.86B | 1.91B | 3.16B | 2.75B | 4.20B | 3.44B | |||||||||||
| Total Current Liabilities | 6.03B | 9.87B | 6.44B | 7.50B | 9.78B | 53.62B | 42.28B | 14.15B | |||||||||||
| Non Current Liabilities | |||||||||||||||||||
| Long Term Debt | 2.70B | 1.30B | 300.00M | 0.00 | 37.44B | 3.35B | 1.19B | 1.61B | |||||||||||
| Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 317.11M | 179.98M | 0.00 | 0.00 | |||||||||||
| Deferred Tax Liabilities Non-Current | 0.00 | 0.00 | 0.00 | 0.00 | 2.69B | 819.58M | 0.00 | 715.09M | |||||||||||
| Other Non-Current Liabilities | 985.00M | 1.07B | 1.49B | 3.45B | 1.40B | 627.21M | 2.33B | 440.23M | |||||||||||
| Total Non-Current Liabilities | 3.69B | 2.37B | 1.79B | 3.45B | 41.54B | 4.80B | 3.53B | 2.76B | |||||||||||
| Other Liabilities | 0.00 | 1.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 | 0.00 | |||||||||||
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 508.40M | 306.68M | 853.73M | 1.24B | |||||||||||
| Total Liabilities | 9.71B
+0% |
12.24B
+26% |
8.23B
-33% |
10.95B
+33% |
51.32B
+369% |
58.42B
+14% |
45.81B
-22% |
16.92B
-63% |
|||||||||||
| Equity | |||||||||||||||||||
| Preferred Stock | 0.00 | 0.00 | 0.00 | 26.50B | 3.81B | 30.00B | 7.05B | 0.00 | |||||||||||
| Common Stock | 3.37B | 3.42B | 3.86B | 3.93B | 4.12B | 4.17B | 42.14B | 42.53B | |||||||||||
| Retained Earnings | -40,226,466,365.00 | -46,014,409,234.00 | -60,929,991,203.00 | -77,796,087,658.00 | -95,182,867,567.00 | -124,671,411,516.00 | -151,059,762,527.00 | 41.91B | |||||||||||
| Accumulated Other Comprehensive Income Loss | 1.39B | 1.58B | 559.35M | -628,116,417.00 | 15.00B | 16.53B | 16.29B | 16.34B | |||||||||||
| Other Total Stockholders Equity | 62.42B | 65.58B | 115.32B | 122.04B | 144.73B | 194.15B | 287.33B | 92.73B | |||||||||||
| Total Stockholders Equity | 26.96B | 24.56B | 58.82B | 74.04B | 72.48B | 74.66B | 201.74B | 193.52B | |||||||||||
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.11B | |||||||||||
| Total Equity | 26.96B
+0% |
24.56B
-9% |
58.82B
+139% |
74.04B
+26% |
72.48B
-2% |
74.66B
+3% |
201.74B
+170% |
194.63B
-4% |
|||||||||||
| Total Liabilities And Total Equity | 36.67B
+0% |
36.80B
+0% |
67.05B
+82% |
84.99B
+27% |
123.80B
+46% |
133.08B
+7% |
247.55B
+86% |
211.55B
-15% |
|||||||||||
| Additional Metrics | |||||||||||||||||||
| Total Investments | 3.42B
+0% |
1.04B
-70% |
32.76B
+3,056% |
47.63B
+45% |
89.29B
+87% |
92.32B
+3% |
185.70B
+101% |
123.80B
-33% |
|||||||||||
| Total Debt | 5.60B
+0% |
5.59B
0% |
3.87B
-31% |
3.09B
-20% |
43.07B
+1,294% |
51.98B
+21% |
37.78B
-27% |
5.66B
-85% |
|||||||||||
| Net Debt | -2,692,071,813.00 | 278.81M | 268.29M | 801.77M | 41.21B | 49.19B | 30.10B | -9,813,265,330.00 | |||||||||||